Wells Fargo’s RAPT Therapeutics RAPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.83K | Sell |
1,229
-20,132
| -94% | -$161K | ﹤0.01% | 5499 |
|
2025
Q1 | $26.1K | Sell |
21,361
-4,444
| -17% | -$5.42K | ﹤0.01% | 5164 |
|
2024
Q4 | $40.8K | Buy |
25,805
+4,336
| +20% | +$6.85K | ﹤0.01% | 5066 |
|
2024
Q3 | $43.2K | Buy |
21,469
+5,580
| +35% | +$11.2K | ﹤0.01% | 5000 |
|
2024
Q2 | $48.5K | Sell |
15,889
-3,402
| -18% | -$10.4K | ﹤0.01% | 4941 |
|
2024
Q1 | $173K | Buy |
19,291
+6,801
| +54% | +$61.1K | ﹤0.01% | 4195 |
|
2023
Q4 | $310K | Sell |
12,490
-15,775
| -56% | -$392K | ﹤0.01% | 3823 |
|
2023
Q3 | $470K | Sell |
28,265
-9,404
| -25% | -$156K | ﹤0.01% | 3553 |
|
2023
Q2 | $704K | Sell |
37,669
-1,278
| -3% | -$23.9K | ﹤0.01% | 3513 |
|
2023
Q1 | $715K | Buy |
+38,947
| New | +$715K | ﹤0.01% | 3379 |
|
2022
Q4 | – | Sell |
-769
| Closed | -$19K | – | 7313 |
|
2022
Q3 | $19K | Buy |
769
+204
| +36% | +$5.04K | ﹤0.01% | 5105 |
|
2022
Q2 | $10K | Sell |
565
-5,756
| -91% | -$102K | ﹤0.01% | 5467 |
|
2022
Q1 | $139K | Sell |
6,321
-7,004
| -53% | -$154K | ﹤0.01% | 4853 |
|
2021
Q4 | $489K | Buy |
13,325
+13,042
| +4,608% | +$479K | ﹤0.01% | 4377 |
|
2021
Q3 | $9K | Sell |
283
-167
| -37% | -$5.31K | ﹤0.01% | 5912 |
|
2021
Q2 | $14K | Sell |
450
-2,202
| -83% | -$68.5K | ﹤0.01% | 5707 |
|
2021
Q1 | $58K | Sell |
2,652
-27,575
| -91% | -$603K | ﹤0.01% | 5399 |
|
2020
Q4 | $597K | Sell |
30,227
-19,748
| -40% | -$390K | ﹤0.01% | 4318 |
|
2020
Q3 | $1.61M | Buy |
49,975
+7,580
| +18% | +$244K | ﹤0.01% | 3431 |
|
2020
Q2 | $1.23M | Buy |
42,395
+29,032
| +217% | +$842K | ﹤0.01% | 3570 |
|
2020
Q1 | $284K | Buy |
13,363
+3,712
| +38% | +$78.9K | ﹤0.01% | 4303 |
|
2019
Q4 | $266K | Buy |
+9,651
| New | +$266K | ﹤0.01% | 4656 |
|